Thomas Perpoint
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Antimicrobial Resistance in Staphylococcus
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
Papers in
-
- COVID-19 Clinical Research Studies 11
- HIV/AIDS drug development and treatment 5
- Antimicrobial Resistance in Staphylococcus 4
- SARS-CoV-2 and COVID-19 Research 4
- Antifungal resistance and susceptibility 3
- Virology 5
- HIV Research and Treatment 4
- Co-authors
- Tristan Ferry (17 shared papers)Christian Chidiac (15 shared papers)François Vandenesch (3 shared papers)Jérôme Étienne (2 shared papers)Florent Valour (9 shared papers)Frederic J. Laurent (6 shared papers)Vinca Icard (4 shared papers)Florence Ader (5 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (6 papers)Clinical Infectious Diseases (4 papers)BMC Infectious Diseases (3 papers)International Journal of Infectious Diseases (2 papers)Frontiers in Medicine (2 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Thomas Perpoint
62 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 103
- Infectious Diseases 847
- Modeling and Simulation 98
- Virology 49
- Ecology 187
- Immunology 123
Countries citing papers authored by Thomas Perpoint
This map shows the geographic impact of Thomas Perpoint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Perpoint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Perpoint more than expected).
Fields of papers citing papers by Thomas Perpoint
This network shows the impact of papers produced by Thomas Perpoint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Perpoint. The network helps show where Thomas Perpoint may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Perpoint, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 258 | |
| 2 | 2020 | 227 | |
| 3 | 2020 | 189 | |
| 4 | 2018 | 112 | |
| 5 | 2018 | 86 | |
| 6 | 2005 | 76 | |
| 7 | 2021 | 75 | |
| 8 | 2023 | 63 | |
| 9 | 2016 | 59 | |
| 10 | 2022 | 58 | |
| 11 | 2020 | 56 | |
| 12 | 2019 | 52 | |
| 13 | 2016 | 42 | |
| 14 | 2022 | 42 | |
| 15 | 2020 | 41 | |
| 16 | 2020 | 36 | |
| 17 | 2017 | 35 | |
| 18 | 2020 | 31 | |
| 19 | 2022 | 28 | |
| 20 | 2016 | 24 |
About Thomas Perpoint
Thomas Perpoint is a scholar working on Infectious Diseases, Virology, Surgery, Neurology and Immunology, having authored 64 papers that have together received 1.9k indexed citations. Recurring topics across this work include Orthopedic Infections and Treatments (11 papers), COVID-19 Clinical Research Studies (11 papers), HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Antifungal resistance and susceptibility (3 papers) and Malaria Research and Control (3 papers). The work is most often cited by research in Infectious Diseases (847 citations), Modeling and Simulation (98 citations), Virology (49 citations), Ecology (187 citations) and Immunology (123 citations). Thomas Perpoint has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Tristan Ferry, Christian Chidiac, François Vandenesch, Jérôme Étienne, Florent Valour, Frederic J. Laurent, Vinca Icard, Florence Ader, Patrice André and Christophe Ramière. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, BMC Infectious Diseases, International Journal of Infectious Diseases and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.